Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,533,653 | 226,433 | 68,981 | 63,656 | 52,756 |
| Depreciation Amortization | 138,162 | 31,535 | 25,714 | 18,492 | 14,218 |
| Income taxes - deferred | -104,588 | -10,077 | -55,491 | -47,120 | -23,567 |
| Accounts receivable | -107,685 | -47,367 | -55,290 | -33,061 | -5,604 |
| Other Working Capital | -210,161 | 146,477 | -52,722 | -13,396 | 107,968 |
| Other Operating Activity | 2,000,112 | 130,499 | 152,369 | 53,346 | 10,168 |
| Operating Cash Flow | $182,187 | $477,500 | $83,561 | $41,917 | $155,939 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -77,379 | -64,359 | -58,582 | -35,861 | -36,015 |
| Net Acquisitions | -746,779 | N/A | N/A | -7,152 | -109,882 |
| Purchase Of Investment | -858,258 | -2,572,663 | -792,552 | -658,315 | -485,939 |
| Sale Of Investment | 1,148,116 | 1,654,354 | 857,918 | 598,319 | 539,200 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -122 | N/A |
| Other Investing Activity | 12,054 | -7,518 | 0 | -122 | 0 |
| Investing Cash Flow | $-522,246 | $-990,186 | $6,784 | $-103,131 | $-92,636 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -9 | -34 |
| Common Stock Issued | 128,583 | 144,703 | 1,119,254 | 52,640 | 16,036 |
| Other Financing Activity | 153,046 | 142,992 | 101,992 | 0 | 0 |
| Financing Cash Flow | $281,629 | $287,695 | $1,221,246 | $52,631 | $16,002 |
| Exchange Rate Effect | -67,457 | 3,849 | 4,508 | -3,328 | -4,406 |
| Beginning Cash Position | 1,218,273 | 1,439,415 | 123,316 | 135,227 | 60,328 |
| End Cash Position | 1,092,386 | 1,218,273 | 1,439,415 | 123,316 | 135,227 |
| Net Cash Flow | $-125,887 | $-221,142 | $1,316,099 | $-11,911 | $74,899 |
| Free Cash Flow | |||||
| Operating Cash Flow | 182,187 | 477,500 | 83,561 | 41,917 | 155,939 |
| Capital Expenditure | -77,379 | -64,359 | -58,582 | -35,861 | -36,015 |
| Free Cash Flow | 104,808 | 413,141 | 24,979 | 6,056 | 119,924 |